LinkedIn·Friday, 7 August 2026·19d ago
There's so much stuff hiding in your PBMCs! But you need to read it out properly: what's my T-cell diversity, are they expanding, what are…
Sander Wuyts
Extract real value out of TCR repertoires | 🔎 CEO ImmuneWatch
There's so much stuff hiding in your PBMCs!
But you need to read it out properly: what's my T-cell diversity, are they expanding, what are they reacting to? That's the info that TCR sequencing can bring you.
We want more labs to see that picture, so together with QIAGEN we're funding the full workflow, free, for up to 4 projects this round: 2 academic, 2 biopharma.
1) QIAGEN's RNA extraction kit, shipped to your lab
2) QIAseq Targeted RNA TCR Panel library prep
3) Full NGS sequencing and clonotype processing
4) Our own DETECT analysts doing the TCR clustering and antigen-TCR annotation
On 2 September we're running a webinar on the grant, and on how we normally approach TCR sequencing analysis, grant or no grant.
Link to register below.
Happy to answer questions in the DMs too.
https://tally.so/r/zxAv90
Cross-referenced
Related on the wire
Last week was a fun week here on LinkedIn 😃
Building a spin-off out of a university lab usually brings a lot of deep scientific knowledge to the table but just a thin layer of…
When I started ImmuneWatch, I was still very much a researcher. Head down in the analysis. Trying to make the technology better, adding…
I'll be honest: When I started my own AI x biology company this was not on my "expectations list" QIAGEN put us on their homepage (!) to…
We're working on something new: The ImmuneWatch Analyser Ideal for those doing immunomonitoring with TCR repertoires. The idea of this…
This announcement is so cool that I decided to make a little flag 🏁 ImmuneWatch is partnering up with QIAGEN to bring free TCR sequencing…